Applications Open | 1 January - 29 February 2024 AEST* (CLOSED)

*no late applications will be considered

Offer of Places for Participants | 6 - 10 May 2024

Faculty and Participant Orientation/Briefings | 6 September and 13 September 2024

Participants are required to commit to full-time participation in the 6-day Workshop program, all pre-Workshop online activities in the 2 weeks prior and to contribute to long term project evaluation.

All selected participants are required to pay the Workshop Participation Fee of AUD$3,000.00 or AUD $600 (participants from low middle income countries - World Bank listing). Including 1.75% + A$0.30 for domestic cards and 3.5% + A$0.30 for international cards + 10% GST (for Australian transactions ONLY).

The Workshop Participation Fee includes:

• Exclusive access to and mentoring by highly experienced clinical experts in oncology;

• Access to Workshop portal, the online resource platform for all Workshop material;

• Accommodation at the Workshop venue from 22-27 September 2024;

• Food and beverages throughout the duration of the Workshop;

• Shuttle bus service from Sydney airport to the Workshop venue on Sunday 22 September 2024 and from the Workshop venue to Sydney airport on Friday 27 September 2024.

PLEASE NOTE: Any additional and unauthorised travel expenses will not be reimbursed. Participants are responsible for their own return interstate or international airfares.

Registration

The link to the registration form will be sent to selected applicants in May 2024. Only fully completed online registrations will be accepted. The registration will only be confirmed upon receipt of full payment. If full payment is not received by the deadline, the Participant’s offer of a place will be withdrawn and provided to the next applicant on the waiting list.

Methods of Payment

Visa · American Express · Mastercard · eftpos Australia · Apple Pay · Google Pay.

Cancellation & Refunds

Registration fees are not refundable.

The Workshop Steering Committee will evaluate the applications and base its decision on a number of factors including:

• Quality and feasibility of the proposed protocol concept and the letters of commitment submitted;

• Individual career path in medical training and competence in clinical cancer research;

• Support of relevant departments and/or institutions to help conduct the clinical trial.

The selection of applications is at the sole discretion of the Workshop Steering Committee. Whilst feedback on the application process and selection is welcome, the Workshop Steering Committee will not enter into any discussions regarding the final decision. Applications will be accepted from those based in East Asia and Pacific regions.

ELIGIBILITY CRITERIA

⦿ Applications will be accepted from cancer clinical researchers working in any oncology-related discipline, including medical, surgical or radiation oncology, palliative care, psycho-oncology, pathology, radiology, nuclear medicine, nursing, allied health, and others.

⦿ Preference will be given to applicants near the end of their clinical and/or research training, including fellows and recently registered specialists who completed training within the last 5 years.

⦿ Applicants from other professions involved in cancer research will be considered.

⦿ A limited number of applicants not based in the Asia Pacific may be accepted.

⦿ Be fluent in written and spoken English and have good computer skills.

⦿ Applicants are required to accept and comply with the ACORD 2024 Workshop Terms and Conditions as part of their application.

ASSESSMENT CRITERIA

⦿ Quality and feasibility of the clinical research proposal.

⦿ Applicant’s commitment to participation in the workshop and evaluation.

⦿ Supervisor’s, institution’s and/or group’s commitment to support the proposed research.

⦿ Track records of the applicant, and of their supporting institution(s) and/or group(s): extent to which participation at the ACORD PDW will help the applicant, proposal and supporters succeed.

ASSESSMENT PRINCIPLES

⦿ Reviewers rate applications on the promise (potential) of the proposed idea, applicant, and their local support

⦿ We are seeking for promising applicants, proposals and support that we can help succeed.

⦿ Applicants may have little or no track record in clinical research, but we are looking for promise which can also be manifested by evidence of interest, enthusiasm, inquisitiveness, etc. We also consider how beneficial workshop participation would be to the applicant’s clinical research career.

⦿ Proposed study. How good is the underlying idea and what are the prospects of turning this idea into a protocol for a study that is likely to be successful? Proposed studies are often over-ambitious and/or unsuitable as an applicant’s first ever study. However, we are looking for ideas that have the potential to be successful, perhaps with major simplification and/or scaling back. For example, the applicant might have proposed a large-scale phase 3 trial which is unlikely to be feasible, but a phase 2 trial assessing activity, or even a phase 1 trial assessing the intervention’s feasibility might be better, and more feasible.

⦿ Support of Supervisors, institutions, and groups range from world-leaders to neophytes: how strongly can/will they help the applicant? How much difference will the participant attendance at ACORD make to the supporting institution or group?

SUPPORTING DOCUMENTATION

⦿ Concept outline for the proposed clinical research study. (download template)

⦿ Current 2024 curriculum vitae including a list of peer-reviewed publications.

⦿ Applicant’s letter including their background, career plans, reasons for attending the workshop, and assurances regarding participation in the workshop.

⦿ Letter of support from applicant’s supervisor, including a written assurance that reasonable efforts will be made to support the proposed clinical research project.